ConductScience.org, home

Paper2593166

Model predicting survival in stage I melanoma based on tumor progression.

Clark WH and 7 others. J Natl Cancer Inst, 1989. Cited by 1,021 papers, by iCite.

Cite this record

ConductScience Library. Model predicting survival in stage I melanoma based on tumor progression. Papers, record 2593166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2593166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Model predicting survival in stage I melanoma based on tumor progression.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1989
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,021
iCite
Relative citation ratio, by iCite
23.6
iCite
Revised in PubMed
2023-02-08
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clark WH JrW H
2Elder DED E
3Guerry D 4thD
4Braitman LEL E
5Trock BJB J
6Schultz DD
7Synnestvedt MM
8Halpern ACA C

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Female
Humans
Male
Models, Biological
Neoplasm Staging
Probability
Prognosis
Regression Analysis
Survival Rate
Time Factors

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-16520NCI NIH HHSUnited StatesP01CA016520PubMed and NIHNIH RePORTER
CA-25298NCI NIH HHSUnited StatesR01CA025298PubMed and NIHNIH RePORTER
CA-25874NCI NIH HHSUnited StatesP01CA025874PubMed and NIHNIH RePORTER
P30CA016520NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in2313736Lymphoid dependency and cutaneous melanoma.https://conductscience.org/library/papers/2313736

Source PubMed

Download CSV of comments and corrections

Cited by306

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,021 citations.

PMIDTitleJournalYearIn PapersSource
42738309Hypoxia-Inducible Factor-1α Gene (HIF1A) rs11549465 (1772 C>T) Polymorphism, Body Mass Index, Smoking, and Cutaneous Melanoma: An Observational Case-Control Study.Cancers (Basel)2026https://conductscience.org/library/papers/42738309PubMed
42558427From biology to morphology and treatment: the current role of pathology in penile cancer - a narrative review.Front Oncol2026https://conductscience.org/library/papers/42558427PubMed
42516025The Prognostic Role of CD8+ Tumor-Infiltrating Lymphocyte Density in Head and Neck Mucosal Melanoma.Otolaryngol Head Neck Surg2026https://conductscience.org/library/papers/42516025PubMed
42515829Spatial T lymphocyte infiltration into the primary melanoma tumor associates with survival.Melanoma Res2026https://conductscience.org/library/papers/42515829PubMed
42511497Association of BRAF Mutation Status with Histopathological Characteristics and Survival Outcomes in Stage II-III Malignant Melanoma.Int J Mol Sci2026https://conductscience.org/library/papers/42511497PubMed
42505240
Interleukin-1β Gene (IL-1B) rs16944 (-511 C > T) Promoter Polymorphism Is Associated with Cutaneous Melanoma Susceptibility, Stage, and Anatomical Localization in a Northern Italian Case-Control Study.
Curr Oncol2026https://conductscience.org/library/papers/42505240PubMed
42457919The tumoural landscape of lymphocytes and immune pathways in immunotherapy-treated melanoma patients.Genes Immun2026https://conductscience.org/library/papers/42457919PubMed
42356028Assessment of Risk Factors Correlated with Satellites and In-Transit Metastases in Primary Cutaneous Melanomas.Medicina (Kaunas)2026https://conductscience.org/library/papers/42356028PubMed
42085373EGFR-targeted affibody-polyIC polyplex kills EGFR-overexpressing cancer cells without activating the EGFR.PLoS One2026https://conductscience.org/library/papers/42085373PubMed
42075611Uncovering the Intricate and Heterogeneous Cellular Microenvironment of Cutaneous Melanoma.Medicina (Kaunas)2026https://conductscience.org/library/papers/42075611PubMed
41893014From Immunobiology to Clinical Application: Tumor-Infiltrating Lymphocytes in Melanoma.J Pers Med2026https://conductscience.org/library/papers/41893014PubMed
41681896ABCB5: A Key Regulator Linking Stem Cell Plasticity, Tumor Microenvironment, and Therapy Resistance in Cutaneous Melanoma.Cancers (Basel)2026https://conductscience.org/library/papers/41681896PubMed
41604042Canine melanomas: MiTF and p38 expression and its correlation with the presence of lymphocytic infiltrate, proliferation, and survival.Vet Res Commun2026https://conductscience.org/library/papers/41604042PubMed
41576931IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma.Cancer Cell2026https://conductscience.org/library/papers/41576931PubMed
41559679GLUT1 expression, lymphocyte distribution and CD3+ T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/41559679PubMed
41249810Low GATA3 predicts worse survival in penile cancer.Sci Rep2025https://conductscience.org/library/papers/41249810PubMed
40941017Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge.Cancers (Basel)2025https://conductscience.org/library/papers/40941017PubMed
40608341Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma.JAMA Netw Open2025https://conductscience.org/library/papers/40608341PubMed
40595851Machine learning to detect melanoma exploiting nuclei morphology and Spatial organization.Sci Rep2025https://conductscience.org/library/papers/40595851PubMed
40549109Tumor-Infiltrating Lymphocyte Therapy for the Treatment of Metastatic Melanoma.Am J Clin Dermatol2025https://conductscience.org/library/papers/40549109PubMed

See all 306 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2593166

GET https://conductscience.org/api/papers/v1/2593166/cited_by?page=2